High-Priority Pathogen Infection Prevention

The contract seeks preventive solutions non-vaccine approaches to combat infections caused by high-priority pathogens including Pseudomonas aeruginosa and Shigella, targeting urgent public health and defense-related threats. It is issued under the Defense Health Agency within the Department of Defense and is classified as a subcontract, with the North American Industry Classification System code 325412 indicating focus on pharmaceutical preparation manufacturing. The initiative aims to advance innovative, non-pharmaceutical interventions such as antimicrobial barriers, prophylactic agents, or environmental controls that interrupt transmission or reduce pathogen load without relying on vaccines. Responses are due by October 30, 2026, and the performance location is designated as Frederick, though the full address and point of contact details are not provided. The solicitation remains open to qualified entities capable of delivering scalable, evidence-based preventive technologies aligned with military and civilian health protection needs.